A Study of IDH305 in Patients With Advanced Malignancies That Harbor IDH1R132 Mutations
Novartis
Novartis
National Cancer Institute (NCI)
Actuate Therapeutics Inc.
Rigel Pharmaceuticals
The Children's Hospital of Zhejiang University School of Medicine
M.D. Anderson Cancer Center
Cancer Research UK
Cancer Research UK
Cancer Research UK
Cancer Research UK
National Cancer Institute (NCI)
Deciphera Pharmaceuticals, LLC
Novartis
Bristol-Myers Squibb
Shenzhen BinDeBio Ltd.
Children's Oncology Group
INSYS Therapeutics Inc
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Case Comprehensive Cancer Center
Case Comprehensive Cancer Center